# US 2019/0376150 A1 · Kit for detecting silent sexually transmitted diseases (sstds) in a urine sample

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376150 A1
- Document ID: US20190376150A1
- Status: Published application
- Kind: A1
- Application number: 16/487,697
- Filed: 2017-03-03
- Published: 2019-12-12
- Earliest claimed: 2017-03-03
- Assignees: Universidad De La Frontera
- Applicants: Universidad De La Frontera
- Inventors: Raul Segundo SANCHEZ GUTIERREZ; Alejandra Pilar ANDANA VARGAS; Camen Gloria ILI GANGAS; Doris MENZEL MIDDELMANN; Jaime Patricio LOPEZ MENDEZ; Juan Carlos ROA STRAUCH; Priscilla Solange BREBI MIEVILLE
- Web page: https://patentgrep.com/patent/US20190376150A1

## CPC

- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 1/705: {for herpetoviridae, e.g. herpes simplex, varicella zoster}
- C12Q 1/68: involving nucleic acids
- C12Q 1/689: for bacteria
- C12Q 1/708: {for papilloma}
- G01N 33/50: Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q)
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A diagnostic kit for simultaneously detecting at least seven silent sexually transmitted diseases (SSTDs) having a diagnostic strip which has detection zones with at least eight probes with SEQ ID NOs: 3, 6, 9, 12, 15, 18, 21, 24; at least 14 primers with SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23; an instruction manual; a nucleotide sequence set for simultaneously detecting at least seven silent sexually transmitted diseases (SSTDs); use of the kit to detect at least the following pathogens: Herpes Virus type 1, Herpes Virus type 2, Chlamydia trachomatis, Ureaplasma urealitycum, Mycoplasma hominis, Mycoplasma genitalium, and Human papillomavirus (HPV); a method for simultaneously detecting at least seven silent sexually transmitted diseases (SSTDs).

## Claims

### Claim 1

A diagnostic kit for simultaneously detecting at least 7 silent sexually transmitted diseases (STDs), comprising:
a diagnostic strip, comprising detection zones with at least 8 probes of SEQ ID NOs: 3, 6, 9, 12, 15, 18, 21, 24;
at least 14 primers of SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23;
instruction manual.

### Claim 2 (depends on 1)

A nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 1.

### Claim 3 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 2.

### Claim 4 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 3.

### Claim 5 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 4.

### Claim 6 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 5.

### Claim 7 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 6.

### Claim 8 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 7.

### Claim 9 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 8.

### Claim 10 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 9.

### Claim 11 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 10.

### Claim 12 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 11.

### Claim 13 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 12.

### Claim 14 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 13.

### Claim 15 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 14.

### Claim 16 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 15.

### Claim 17 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 16.

### Claim 18 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 17.

### Claim 19 (depends on 1)

The nucleotide sequence according to claim 1 wherein the sequence consists or has a similarity of at least 90% to SEQ ID NO: 18.

### Claim 20

(canceled)

### Claim 21 (depends on 20)

A sequence set wherein their sequences have at least 90% similarity to the sequences of set of sequences of claim 20.

### Claim 22

(canceled)

### Claim 23

A method for simultaneously detecting at least 7 silent sexually transmitted diseases (STDs), comprising the steps of:
i. extracting DNA from a body fluid sample by cell lysis, and centrifuging to obtain a pellet containing DNA samples to be amplified;
ii. amplifying by Multiplex PCR, using the primers described in SEQ ID NOs: 1, 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19, 20, 22, 23;
iii. hybridizing the amplified DNA in step ii), using the probes described in SEQ ID NOs: 3, 6, 9, 12, 15, 18, 21, 24;
iv. detecting the presence or absence of the pathogens of interest in a nylon strip comprising the probes of SEQ ID NOs: 3, 6, 9, 12, 15, 18, 21, 24.

### Claim 24 (depends on 23)

The method of claim 23 wherein step i), body fluid samples are selected from urine, blood, saliva, urethral secretion, seminal fluid, vaginal secretion.

### Claim 25 (depends on 23)

The method of claim 23, wherein in step iv) the pathogen detected is at least one of the pathogens selected from the group consisting of Herpes Virus type 1, Herpes Virus type 2, Chlamydia trachomatis, Ureaplasma urealitycum, Mycoplasma hominis, Mycoplasma genitalium, and Human papillomavirus (HPV).
